Fig. 1
From: The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus
Serum levels of autoantibodies against ribosomal proteins in SLE and healthy donors. Autoantibodies directly against native ribosomal P heterocomplex (Rib-PELISA) (a), recombinant ribosomal P0 protein (Rib-P0) (b), recombinant ribosomal P1 (Rib-P2) (c) and recombinant ribosomal P2 protein (Rib-P2) (d) were measured by enzyme-linked immunosorbent assay. Dotted lines represent the distinct cut-offs based on ROC curve analysis at the specificities of 99%. The prevalence of antibodies are indicated in percentage for each cohort. Numbers in brackets represent serum positive and total cases, respectively. Data represent at least three independent experiments